Subtype
Brain Neoplasm
CI-CAN-00002030Explore in graph →
Non-malignant511 active trials34 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002030Explore in graph →
Clinical trials
2,117 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03778541 | HFSRT With Concurrent TMZ for Large BMs | unknown | Phase 3 | 224 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT02393131 | Neurocognitive Outcome of Conformal WBRT w/wo Hippocampal Avoidance for Brain Metastases | unknown | N/A | 70 | National Taiwan University HospitalOTHER | 1 | Jul 19, 2019 | clinicaltrials |
| NCT03392545 |
| Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)(InSituVac1) |
| unknown |
| Phase 1 |
| 30 |
| Beijing Tiantan HospitalOTHER |
| 1 |
| Jul 11, 2019 |
| clinicaltrials |
| NCT03516162 | Linking Digital Smartphone Behaviour With Brain Function(SmartSurgery) | unknown | — | 100 | University of ZurichOTHER | 1 | May 24, 2019 | clinicaltrials |
| NCT03933241 | Nasal Irrigation Apply in Patients After Transsphenoidal Pituitary Tumor Resection | unknown | N/A | 262 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT03916757 | V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer(GBM) | unknown | Phase 2 | 20 | Immunitor LLCINDUSTRY | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03402425 | The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and Adolescents(BUF) | unknown | N/A | 200 | Rigshospitalet, DenmarkOTHER | 1 | Mar 28, 2019 | clinicaltrials |
| NCT03773705 | Impact of Nasoseptal Flap Harvest Technique on Olfaction Following Endoscopic Transsphenoidal Pituitary Surgery | unknown | N/A | 20 | Unity Health TorontoOTHER | 1 | Mar 15, 2019 | clinicaltrials |
| NCT02726568 | High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases | unknown | Phase 2 | 30 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 19, 2019 | clinicaltrials |
| NCT03815838 | Molecular Imaging of Pituitary Adenomas(MIMOPA) | unknown | N/A | 20 | Cardiff UniversityOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03754530 | Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation | unknown | Phase 2 | 162 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 0 | Nov 27, 2018 | clinicaltrials |
| NCT03717454 | Dopamine D2 Receptors(D2R) Imaging in Prolactinomas | unknown | N/A | 50 | Zhebao WuOTHER | 0 | Nov 20, 2018 | clinicaltrials |
| NCT03719781 | Postoperative Cognitive Dysfunction in Patients Undergoing Pituitary Removal Surgery | unknown | — | 90 | Kocaeli UniversityOTHER | 1 | Oct 25, 2018 | clinicaltrials |
| NCT03714763 | Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA) | unknown | N/A | 50 | Zhebao WuOTHER | 0 | Oct 22, 2018 | clinicaltrials |
| NCT02672241 | Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children | unknown | Phase 2 | 30 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 16, 2018 | clinicaltrials |
| NCT03400865 | Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas | unknown | N/A | 30 | Zhebao WuOTHER | 1 | Oct 16, 2018 | clinicaltrials |
| NCT03675230 | Study of Tomotherapy HD in Medulloblastoma | unknown | N/A | 220 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03247127 | Memory Preservation of Hippocampal Avoidance Whole Brain Radiotherapy | unknown | N/A | 30 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT03633552 | Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma | unknown | Phase 3 | 62 | Mashhad University of Medical SciencesOTHER | 1 | Aug 16, 2018 | clinicaltrials |
| NCT03626818 | The Impact of Neurocognitive Function in Patients With Multiple Brain Metastases Receiving Whole Brain Radiation Therapy | unknown | — | 125 | Guangdong Association of Clinical TrialsOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT03619694 | Role of MR Spectroscopy in Brain Tumors | unknown | — | 100 | Assiut UniversityOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT03615391 | Predictive Role and HuR Mechanisms of Regulation in the Brain Tumours(HUR) | unknown | — | 140 | Central Hospital, Nancy, FranceOTHER | 1 | Aug 3, 2018 | clinicaltrials |
| NCT02233049 | Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication(BIOMEDE) | unknown | Phase 2 | 250 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT03591315 | Clinical Study of Structural and Functional Evaluation of the Visual Pathway | unknown | — | 60 | Xiangya Hospital of Central South UniversityOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT03586401 | Creating a Decision Support System for the Corporate Management of Physical Therapy | unknown | — | 1,000 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 1 | Jul 13, 2018 | clinicaltrials |
| NCT02655536 | Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial(BRILLIANT) | unknown | Phase 2 | 109 | National Taiwan University HospitalOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT01857453 | Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas(RSMA2010) | unknown | Phase 2 | 97 | Central Hospital, Nancy, FranceOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT03525301 | Short Course Radiation Therapy in Palliative Treatment of Brain Metastases | unknown | N/A | 108 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | May 18, 2018 | clinicaltrials |
| NCT03520829 | Protocol for Evaluating a Planning Algorithm for Gamma Knife Radiosurgery(SPEED) | unknown | — | 30 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | May 17, 2018 | clinicaltrials |
| NCT01847833 | Advanced MRI Applications Development | unknown | — | — | Massachusetts General HospitalOTHER | 1 | Mar 26, 2018 | clinicaltrials |
| NCT03462914 | Comparative Study Between Different Approaches to CPA-petroclival Meningiomas | unknown | — | 80 | Assiut UniversityOTHER | 0 | Mar 13, 2018 | clinicaltrials |
| NCT02840123 | Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines | unknown | Phase 1 | 10 | Fundació Sant Joan de DéuOTHER | 1 | Mar 2, 2018 | clinicaltrials |
| NCT03404414 | Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT | unknown | Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Jan 19, 2018 | clinicaltrials |
| NCT03356600 | Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer | unknown | Phase 2 | 44 | Shanxi Province Cancer HospitalOTHER | 0 | Dec 11, 2017 | clinicaltrials |
| NCT03366376 | Hippocampus-sparing WBRT and Simultaneous Integrated Boost for Multiple Brain Metastases From NSCLC(KROG17-06) | unknown | Phase 2 | 80 | Samsung Medical CenterOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT03353025 | Study on Therapy of Non-invasive Prolactinoma(TNAPA) | unknown | N/A | 394 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Nov 24, 2017 | clinicaltrials |
| NCT03294486 | Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients(ONCOVIRAC) | unknown | Phase 1 / Phase 2 | 78 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02149459 | Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy(SMC 0712-13) | unknown | Phase 1 | 18 | Sheba Medical CenterOTHER_GOV | 1 | Oct 27, 2017 | clinicaltrials |
| NCT03309319 | A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas | unknown | N/A | 24 | Zhaoyun ZhangOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT03282058 | Silastic Stent Study | unknown | N/A | 26 | University of British ColumbiaOTHER | 0 | Sep 13, 2017 | clinicaltrials |
| NCT02672995 | Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial | unknown | Phase 1 | 36 | National Taiwan University HospitalOTHER | 1 | Aug 18, 2017 | clinicaltrials |
| NCT03166592 | Evaluation of Intra Axial Brain Masses Based on Magnetic Resonance in Adults | unknown | — | 150 | Assiut UniversityOTHER | 1 | Aug 16, 2017 | clinicaltrials |
| NCT03228511 | Endoscopic-assisted Microsurgical Removal of Cerebellopontine Angle Lesions | unknown | N/A | 1 | Assiut UniversityOTHER | 0 | Jul 25, 2017 | clinicaltrials |
| NCT03216148 | 18F-FET PET in Childhood Brain Tumours | unknown | Phase 2 | 160 | Charite University, Berlin, GermanyOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT03132259 | Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach | unknown | Phase 4 | 124 | Mahidol UniversityOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT03164148 | Heart Rate Variability (HRV) in Pituitary Adenoma | unknown | N/A | 50 | Seoul St. Mary's HospitalOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT02152748 | Disease Progression and Treatment-induced Alterations in Glioblastoma | unknown | — | 60 | Medical University of ViennaOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT03068520 | Can Hybrid PET-MRI Differentiate Between Radiation Effects and Disease Progression? | unknown | N/A | 140 | Assuta Medical CenterOTHER | 1 | Mar 21, 2017 | clinicaltrials |
| NCT02428972 | Assessment of Cognitive Functions and Quality of Life in Patients Undergoing Surgery for Supratentorial Brain Tumor | unknown | N/A | 30 | All India Institute of Medical SciencesOTHER | 0 | Jan 24, 2017 | clinicaltrials |
| NCT02015728 | Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors(SEED) | unknown | N/A | 20 | Seattle Children's HospitalOTHER | 1 | Dec 15, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jul 23, 2019source: clinicaltrials